Diagnostic and clinical utility of whole genome sequencing in a cohort of undiagnosed Chinese families with rare diseases

32Citations
Citations of this article
78Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Rare diseases are usually chronically debilitating or even life-threatening with diagnostic and therapeutic challenges in current clinical practice. It has been estimated that 80% of rare diseases are genetic in origin, and thus genome sequencing-based diagnosis offers a promising alternative for rare-disease management. In this study, 79 individuals from 16 independent families were performed for whole-genome sequencing (WGS) in an effort to identify the causative mutations for 16 distinct rare diseases that are largely clinically intractable. Comprehensive analysis of variations, including simple nucleotide variants (SNVs), copy-number variations (CNVs), and structural variations (SVs), was implemented using the WGS data. A flexible analysis pipeline that allowed a certain degree of misclassification of disease status was developed to facilitate the identification of causative variants. As a result, disease-causing variants were identified in 10 of the 16 investigated diseases, yielding a diagnostic rate of 62.5%. Additionally, new potentially pathogenic variants were discovered for two disorders, including IGF2/INS-IGF2 in mitochondrial disease and FBN3 in Klippel–Trenaunay–Weber syndrome. Our WGS analysis not only detected a CNV associated with 3p deletion syndrome but also captured a simple sequence repeat (SSR) variation associated with Machado–Joseph disease. To our knowledge, this is the first time the clinical WGS analysis of short-read sequences has been used successfully to identify a causative SSR variation that perfectly segregates with a repeat expansion disorder. After the WGS analysis, we confirmed the initial diagnosis for three of 10 established disorders and modified or corrected the initial diagnosis for the remaining seven disorders. In summary, clinical WGS is a powerful tool for the diagnosis of rare diseases, and its diagnostic clarity at molecular levels offers important benefits for the participating families.

References Powered by Scopus

Fast and accurate short read alignment with Burrows-Wheeler transform

34835Citations
N/AReaders
Get full text

The genome analysis toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

19166Citations
N/AReaders
Get full text

ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data

10353Citations
N/AReaders
Get full text

Cited by Powered by Scopus

A guide for the diagnosis of rare and undiagnosed disease: beyond the exome

171Citations
N/AReaders
Get full text

Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study

98Citations
N/AReaders
Get full text

Genetic testing for the epilepsies: A systematic review

80Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Liu, H. Y., Zhou, L., Zheng, M. Y., Huang, J., Wan, S., Zhu, A., … Lu, Y. (2019). Diagnostic and clinical utility of whole genome sequencing in a cohort of undiagnosed Chinese families with rare diseases. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-55832-1

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 25

74%

Researcher 6

18%

Professor / Associate Prof. 3

9%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 22

52%

Medicine and Dentistry 10

24%

Agricultural and Biological Sciences 7

17%

Engineering 3

7%

Save time finding and organizing research with Mendeley

Sign up for free